6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
Just now	Press Release Apr 29 2026
Just now	Press Release Apr 29 2026
Just now	Press Release Apr 29 2026
Just now	Press Release Apr 29 2026
Just now	Press Release Apr 29 2026

About

Cns Pharmaceuticals Inc (NASDAQ:CNSP) — investor relations, events, news, and company updates on 6ix.

Latest News

CNS Pharmaceuticals Launches New Corporate Strategy Focused on Building a High-Value Neurology and Oncology Pipeline

CNS Pharmaceuticals Appoints Lynne Kelley, MD, FACS, as Chief Medical Officer, Completing Executive Leadership Team

CNS Pharmaceuticals Appoints Multiple Key Executives to Drive Company's Recently Initiated Strategic Transformation

CNS Pharmaceuticals Issues Letter to Shareholders

CNS Pharmaceuticals Issues Letter to Shareholders

Recent Videos

Breakthrough in Cancer Treatment Development

Breakthrough in Cancer Treatment Development

Mar 17, 2026

Top 12 🔥Stocks Under $5 🚨 Watchlist for Week of Feb 23, 2026 💰High-Potential GAIN ✅Dont MISS out !

Top 12 🔥Stocks Under $5 🚨 Watchlist for Week of Feb 23, 2026 💰High-Potential GAIN ✅Dont MISS out !

Feb 23, 2026

CNS Pharmaceuticals, Inc. (0001729427) (Filer)

CNS Pharmaceuticals, Inc. (0001729427) (Filer)

Feb 18, 2026

Unveiling the Impact of Glioblastoma and Innovations in Food Data Visualization

Unveiling the Impact of Glioblastoma and Innovations in Food Data Visualization

Feb 08, 2026

Financials

Revenue

$0

Market Cap

$1.33 M

EPS

-35.75

Community Chat

Ask AI